PIPR · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Piper Sandler Companies (PIPR) stock moving?
Piper Sandler's Q3 2026 report was mixed. Net revenues fell 11% quarter over quarter to $443M and adjusted EPS of $0.87 missed the $0.92 consensus, with GAAP pre-tax margin at 15.0%. Against that, nine-month revenues were a record $1.4B, up 15%, corporate investment banking had a record Q3 at $307M, advisory revenues rose 18% year over year, and fixed income posted its best quarter since 2021. Management also declared a $0.20 dividend, authorized a new buyback, and launched European equities trading. Recent news flow is modest: a Francis Medical advisory mandate on Nov 10, an EJF co-placement on Oct 30, and a President share sale of about $2.68M on Nov 3, which is routine insider selling. The stock fell from $68.72 to $63.81 on the Oct 30 report, on about twice its normal volume. It then recovered to $70.22 on Nov 4, before easing back to $66.75 on Nov 10. Trading volume has declined over the last several sessions, and the $63–64 area held as support after the earnings drop. No analyst rating on PIPR itself appears in the input; the analyst notes listed cover other companies.
News behind the analysis
- Piper Sandler Reports Q3 2026 Financial ResultsQ3 net revenues fell to $443M and adjusted EPS declined, while nine-month net revenues reached a record $1.4B, up 15%. The company also declared a $0.20 quarterly dividend and a new share repurchase authorization.
- Piper Sandler Q3 Adj. EPS $0.87 Misses $0.92 Estimate, Sales $443.047M Miss $463.290M EstimateAdjusted EPS of $0.87 and sales of $443.0M both came in below consensus estimates of $0.92 and $463.3M. The shares fell about 7% intraday on the day of the report.
- Piper Sandler Q3 2026 Earnings Call TranscriptTranscript of the third-quarter 2026 earnings call, where management discussed results, advisory growth and fixed income activity.
- Piper Sandler Serves as Exclusive Financial Advisor to Francis MedicalPiper Sandler acted as exclusive financial advisor to Francis Medical on a financing tied to its Vanquish Water Vapor Ablation System. The mandate adds to the firm's advisory pipeline, though no deal size was disclosed in the input.
- Piper Sandler President Debbra L. Schoneman Sells SharesPresident Debbra L. Schoneman sold 39,708 shares worth about $2.68M. This is an insider sale and is not a company-level signal.
- Piper Sandler Chief Investment Strategist Analyzes Market Performance TrendsChief investment strategist Michael Kantrowitz commented on the unusual outperformance of Wall Street's least-favored stocks over highly rated names. This is market commentary rather than company-specific news.
- Piper Sandler Acts as Co-Placement Agent for EJF Capital SecuritizationPiper Sandler served as co-placement agent for EJF Capital's $273 million TruPS Financials Note Securitization. This adds to the firm's fixed income and structured finance activity.
About Piper Sandler Companies
Piper Sandler is a mid-sized, Minneapolis-based investment bank. It gives advice on deals and raises money for corporations, municipalities and financial institutions. It stands out for its deep specialization in particular sectors, especially bank and financial-services M&A, where it advised on six of the ten largest bank deals in Q3 2026, and for its large public-finance business.
How it makes money
Investment banking brings in roughly 70% of net revenue. Most of that comes from M&A and other advisory fees, which are about half or more of total revenue. Smaller amounts come from underwriting corporate stock and debt and municipal bond deals. Institutional brokerage, meaning equity and fixed-income trading for professional investors, makes up roughly 20–25%. The remainder is interest and investment income. Full-year 2025 revenue was about $1.9 billion.
What usually moves PIPR
- M&A deal volumes, especially bank and private-equity deals
- Equity and debt capital-markets activity
- Interest-rate moves affecting municipal issuance and fixed-income trading
- Market volatility and trading volumes
- Compensation costs and capital returns (dividends, buybacks)